Practical Clinical Trials: Increasing the Value of Clinical Research for Decision Making in Clinical and Health Policy

JAMA

Volumn 290, Issue 12, 2003, Pages 1624-1632

  Tunis, Sean R ^a   Stryer, Daniel B ^b   Clancy, Carolyn M ^b  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b Mailstop S3 02 01   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CITALOPRAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN MESYLATE; FINASTERIDE; FLUOXETINE; HYPERICUM PERFORATUM EXTRACT; PAROXETINE; PLACEBO; TERAZOSIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL AORTA ANEURYSM; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE THERAPY; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DISABILITY; DISEASE ACTIVITY; DYSPEPSIA; DYSTHYMIA; EMPHYSEMA; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; KNEE ARTHROSCOPY; KNEE OSTEOARTHRITIS; LOW BACK PAIN; MANIPULATIVE MEDICINE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; OSTEOPOROSIS; OUTCOMES RESEARCH; PATIENT SATISFACTION; PHYSIOTHERAPY; PRACTICAL CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; COST BENEFIT ANALYSIS; DECISION MAKING; ECONOMICS; ETHICS; MANAGEMENT; METHODOLOGY; NEEDS ASSESSMENT; OUTCOME ASSESSMENT; PATIENT SELECTION; STANDARD; STATISTICS; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; COST-BENEFIT ANALYSIS; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; NEEDS ASSESSMENT; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; POLICY MAKING; QUALITY OF HEALTH CARE; RESEARCH DESIGN; RESEARCH SUPPORT; UNITED STATES;

EID: 0141684982     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.12.1624     Document Type: Review

References (66)

1. Wennberg J, Gittelsohn A. Small area variation in health care delivery. Sci Am. 1973;182:1102-1108.
2. Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998;76:517-563.
3. Eddy DM, Billings J. The quality of medical evidence: implications for quality of care. Health Aff (Millwood). 1988;7:19-32.
4. McNeil BJ. Shattuck lecture-hidden barriers to improvement in the quality of care. N Engl J Med. 2001;345:1612-1620.
5. Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press; 1990.
6. Steiner CA, Powe NR, Anderson GF, Das A. Technology coverage decisions by health care plans and considerations by medical directors. Med Care. 1997;35:472-489.
7. Garber AM. Evidence-based coverage policy. Health Aff (Millwood). 2001;20:62-82.
8. Antman K, Lagakos S, Drazen J. Designing and funding clinical trials of novel therapies. N Engl J Med. 2001;344:762-763.
9. Altman SH, Parks-Thomas C. Controlling spending for prescription drugs. N Engl J Med. 2002;345:855-856.
10. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-1287.
11. Mulrow CD, Williams JW Jr, Trivedi M, et al. Treatment of Depression: Newer Pharmacotherapies, Rockville, Md: Agency for Health Care Policy and Research; 1999. AHCPR publication 99-E014.
12. Lomas J, Anderson G, Enkin M, et al. The role of evidence in the consensus process: results from a Canadian consensus exercise. JAMA. 1988;259:3001-3005.
13. Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med. 2001;134:600-620.
14. Snow V, Lascher S, Mottur-Pilson C, for the Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001;134:595-599.
15. Tunis SR, Kang JL. Improvements in Medicare coverage of new technology. Health Aff (Millwood). 2001;20:83-85.
16. National Institutes of Health, Grants-OER Home Page. Minimally invasive surgical therapies treatment consortium for benign prostatic hyperplasia. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-01-024.html. Accessed July 5, 2002.
17. Centers for Medicare and Medicaid Coverage. Air-fluidized beds for pressure ulcers. Available at: http: //www.cms.hhs.gov/coverage/8b3-q6.asp. Accessed July 5, 2002.
18. Rafuse J. Education, practice reviews needed to reduce surgical intervention. CMAJ. 1996;155:463-464.
19. Connors AF, Speroff T, Dawson NV, et al, for the SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-897.
20. Soumerai SB, McLaughlin TJ, Spiegelman D, et al. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
21. Naylor CD, Guyatt GH, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, X: how to use an article reporting variation in the outcomes of health services. JAMA. 1996;275:554-558.
22. Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990;1:421-429.
23. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
24. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J Chronic Dis. 1967;20:637-648.
25. Roland M, Torgerson DJ. What are pragmatic trials? BMJ. 1998;316:285.
26. Lepor H, Williford WO, Barry MJ, et al. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. N Engl J Med. 1996;335:533-540.
27. The MTOPS Research Group. The impact of medical therapy on the clinical progression of BPH: results of the MTOPS trial. Paper presented at: American Urological Association Annual Meeting; May 28, 2002; Orlando, Fla. Available at: http://www.niddk.nih.gov/welcome/releases/05-28-02abstract.pdf. Accessed July 25, 2002.
28. Cherkin DC, Deyo RA, Battie M, et al. A comparison of physical therapy, chiropractic manipulation, and provision of an educational booklet for the treatment of patients with low back pain. N Engl J Med. 1998;339:1021-1029.
29. Cherkin DC, Eisenberg D, Sherman KJ, et al. Randomized trial comparing traditional Chinese medical acupuncture, therapeutic massage, and self-care education for chronic low back pain. Arch Intern Med. 2001;161:1081-1088.
30. Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, II: how to use an article about therapy or prevention, B: what were the results and how will they help me in caring for my patients? JAMA. 1994;271:59-63.
31. Dans AL, Dans LF, Guyatt GH, Richardson S, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, XIV: how to decide on the applicability of clinical trials results to your patient. JAMA. 1998;279:545-549.
32. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: part I. Circulation. 2002;106:1015-1021.
33. Williams JW, Barrett J, Oxman T, et al. Treatment of dysthymia and mild depression in primary care: a randomized controlled trial in older adults. JAMA. 2000;284:1519-1526.
34. Dolor RJ, Witsell DL, Hellkamp AS, et al. Comparison of cefuroxime with or without intranasal fluticasone for treatment of rhinosinusitis: the CAFFS Trial: a randomized controlled trial. JAMA. 2001;286:3097-3105.
35. Delaney BC, Wilson S, Roalfe A, et al. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ. 2001;322:898-901.
36. Grimm RH Jr, Margolis KL, Papamertriou VV, et al. Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2001;37:19-27.
37. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk patients randomized to angiotensin-converting enzyme inhibitor or calcium-channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
38. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2000;283:1967-1975.
39. Guyatt GH, Rennie D. The basics: using the medical literature. In: Users' Guides to the Medical Literature. Chicago, Ill: AMA Press; 2002.
40. Barry MJ, Cockett AT, Holtgrewe HL, et al. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 1993;150:351-358.
41. Lederle FA, Wilson SE, Johnson GR, Reinke DB. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437-1444.
42. The United Kingdom Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1445-1452.
43. Rizzo JD, Powe NR. Methodological hurdles in conducting pharmacoeconomic studies. Pharmacoeconomics. 1999;15:339-355.
44. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA. 1996;275:1897-1902.
45. Snow V, Lascher S, Mottur-Pilson C, for the American College of Physicians-American Society of Internal Medicine. Pharmacologic treatment of acute major depression and dysthymia: clinical guideline, part 1. Ann Intern Med. 2000;132:738-742.
46. National Institutes of Health. St John's wort study in mild depression to enroll 300 participants. Health News Daily. 2003;15:5-6.
47. Nathan DG, Varmus HE. The National Institutes of Health and clinical research: a progress report. Nat Med. 2000;6:1201-1204.
48. Schein OD, Katz J, Bass EB, et al. The value of routine preoperative medical testing before cataract surgery: study of medical testing for cataract surgery. N Engl J Med. 2000;342:168-175.
49. Fitzgibbons RJ. Grants On-Line Database [database online]. Abstract of grant HS09860: inguinal hernia management: watchful waiting vs operation. Agency for Healthcare Research and Quality. Available at: http://www.gold.ahrq.gov/index.cfm. Accessed July 20, 2002.
50. Woosley RL. Centers for Education and Research in Therapeutics. Clin Pharmacol Ther. 1994;55:249-255.
51. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions. Circulation. 1976;54(suppl 6):107-117.
52. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-88.
53. Kolata G. VA suggests halt to kind of knee surgery. New York Times. August 24, 2002;A:9(column 4).
54. Getz K, Zisson S. Clinical grants market decelerates. CenterWatch. 2003;10:4-5.
55. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5-14.
56. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-2822.
57. Tunis SR, Korn A, Omaya A. The Role of Purchasers and Payers in the Clinical Research Enterprise. Washington, DC: National Academy Press; 2002.
58. Mello MM, Brennan TA. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Aff (Millwood). 2001;20:101-117.
59. HMO Research Network. HMO Research Network Home Page. Available at: http://hmoresearchnetwork.org/. Accessed June 21, 2002.
60. Buring JE, Jonas MA, Hennekens CH. Large and simple randomized trials. In: US Congress, Office of Technology Assessment. Tools for Evaluating Health Technologies: Five Background Papers. Washington, DC: Office of Technology Assessment; 1995.
61. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R, for the ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ. 1998;316:1337-1343.
62. Djulbegovic B, Clarke M. Scientific and ethical issues in equivalence trials. JAMA. 2001;285:1206-1208.
63. Liliford R. Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway? BMJ. 2003;326:980-981.
64. DeAngelis CD. NIH Director Elias A. Zerhouni, MD, reflects on agency's challenges, priorities. JAMA. 2003:289:1492-1493.
65. US Food and Drug Administration. Improving innovation in medical technology: beyond 2002. Available at: http://www.fda.gov/bbs/topics/NEWS/2003/beyond2002/report.html. Accessed April 30, 2003.
66. Califf RM, DeMets DL. Principles from clinical trials relevant to clinical practice: part II. Circulation. 2002;106:1172-1175.